Meta-analysis does not support continued use of point-of-care serological tests for COVID-19

A systematic review and meta-analysis of 40 studies of antibody testing for novel coronavirus (SARS-CoV-2) has found “major weaknesses” in the evidence base for serological tests. The evidence does not support the continued use of existing point-of-care serological tests for COVID-19. Serological tests to detect antibodies against novel coronavirus (SARS-CoV-2) could improve diagnosis of COVID-19 … Continue reading Meta-analysis does not support continued use of point-of-care serological tests for COVID-19

Advertisement

Editorial: A necessary ban

Published in The Hindu on June 26, 2012 The recent decision by the Ministry of Health and Family Welfare to ban the manufacture, sale, distribution and use of serological (blood) test kits for diagnosing active tuberculosis — both pulmonary and extra-pulmonary — is significant. The blood test diagnoses active TB based on antibody response. The … Continue reading Editorial: A necessary ban

Editorial: Say no to TB blood tests

Published in The Hindu on July 29, 2011 The World Health Organisation recently issued a recommendation against the use of blood tests based on antibody response for diagnosing active tuberculosis, both pulmonary and extra-pulmonary. India's Revised National Tuberculosis Control Programme (RNTCP) has endorsed WHO's advice. Unfortunately, with TB, unlike diseases like HIV, the presence or … Continue reading Editorial: Say no to TB blood tests